<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16(17)</volume><submitter>Gemignani JF</submitter><funding>Conselho Nacional de Desenvolvimento Cient??fico e Tecnol??gico</funding><funding>Funda????o Carlos Chagas Filho de Amparo ?? Pesquisa do Estado do Rio de Janeiro</funding><pubmed_abstract>Emerging evidence suggests that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may have long-term deleterious effects on the central nervous system and even contribute to post-COVID neurological syndromes. Interestingly, inflammation-induced proteolytic processing of the Spike protein of SARS-CoV-2 leads to the generation of peptides capable of aggregating into amyloid fibrils &lt;i>in vitro&lt;/i>. Herein, we investigate the &lt;i>in vitro&lt;/i> effect of a fibrillogenic fragment of the Spike protein [Spike 194-203 (S194)] on the aggregation and toxicity of the Parkinson's disease (PD) protein α-synuclein (αSyn). Our results indicate that S194 fibrils stimulate in a concentration-dependent manner the fibrillation of αSyn monomer, resulting in aggregates with increased cap</pubmed_abstract><journal>ACS chemical neuroscience</journal><pagination>3385-3397</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12412103</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>An Amyloidogenic Fragment of the Spike Protein from SARS-CoV-2 Virus Stimulates the Aggregation and Toxicity of Parkinson's Disease Protein Alpha-Synuclein.</pubmed_title><pmcid>PMC12412103</pmcid><pubmed_authors>Gemignani JF</pubmed_authors><pubmed_authors>Follmer C</pubmed_authors><pubmed_authors>Li MH</pubmed_authors><pubmed_authors>Izecksohn D</pubmed_authors><pubmed_authors>Eliezer D</pubmed_authors><pubmed_authors>Dabkiewicz D</pubmed_authors><pubmed_authors>Cordeiro Y</pubmed_authors><pubmed_authors>Wiecikowski AF</pubmed_authors><pubmed_authors>Netz PA</pubmed_authors></additional><is_claimable>false</is_claimable><name>An Amyloidogenic Fragment of the Spike Protein from SARS-CoV-2 Virus Stimulates the Aggregation and Toxicity of Parkinson's Disease Protein Alpha-Synuclein.</name><description>Emerging evidence suggests that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may have long-term deleterious effects on the central nervous system and even contribute to post-COVID neurological syndromes. Interestingly, inflammation-induced proteolytic processing of the Spike protein of SARS-CoV-2 leads to the generation of peptides capable of aggregating into amyloid fibrils &lt;i>in vitro&lt;/i>. Herein, we investigate the &lt;i>in vitro&lt;/i> effect of a fibrillogenic fragment of the Spike protein [Spike 194-203 (S194)] on the aggregation and toxicity of the Parkinson's disease (PD) protein α-synuclein (αSyn). Our results indicate that S194 fibrils stimulate in a concentration-dependent manner the fibrillation of αSyn monomer, resulting in aggregates with increased cap</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-05-29T19:51:52.713Z</modification><creation>2026-04-08T05:53:02.141Z</creation></dates><accession>S-EPMC12412103</accession><cross_references><pubmed>40845355</pubmed><doi>10.1021/acschemneuro.5c00478</doi></cross_references></HashMap>